Skip to main content

Want a detailed portfolio tracker?

Adaptive Biotechnologies (ADPT) EPS (2019 - 2026)

Adaptive Biotechnologies (ADPT) EPS from Sep 30, 2019 to Mar 31, 2026. The TTM Adaptive Biotechnologies (ADPT) EPS is -$0.32. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual EPS

Quarterly EPS

Adaptive Biotechnologies (ADPT) EPS CAGR table

PeriodCAGR
1 Year TTM-66.57%
3 Years TTM-38.33%
5 Years TTM-22.54%
All Time TTM-17.88%

Annual EPS change of Adaptive Biotechnologies (ADPT)

YearEPSChange
2026-$0.13-67.58%
2025-$0.39-64.15%
2024-$1.08-30.48%
2023-$1.55+10.98%
2022-$1.40-4.58%
2021-$1.47+37.99%
2020-$1.06+93.92%
2019-$0.55N/A

Comparison Adaptive Biotechnologies (ADPT) five years EPS CAGR with competitors

Adaptive Biotechnologies (ADPT) five years EPS CAGR is -22.53%.

TickerNamefive years EPS CAGRUpside
NOTVInotiv, Inc. Common Stock62.28%-376.38%
IQVIQVIA Holdings Inc30.82%-236.75%
MEDPMedpace Holdings Inc29.42%-230.57%
WATWaters Corp15.00%-166.56%
TMOThermo Fisher Scientific Inc14.94%-166.28%
IDXXIdexx Laboratories Inc11.68%-151.81%
MTDMettler-Toledo International Inc10.58%-146.94%
AAgilent Technologies Inc10.55%-146.83%
DGXQuest Diagnostics Inc8.13%-136.07%
QGENQiagen NV3.15%-114.00%
GHGuardant Health Inc1.05%-104.64%